Impact of GERD on Daily Life (NIS)

Completed

• Conditions: GERD

• Registration Number: NCT00545883
• Lead Sponsor: AstraZeneca

Brief Summary

The aim of this study is to gather epidemiological data in a population of GERD patients in primary care with a history of erosive esophagitis (less than or equal to 3 years).

Detailed Description

Not available

Study Timeline

• Study Start: 2006-06
• Study First Submitted: 2007-10-15
• Study First Submitted QC: 2007-10-16
• Study First Posted: 2007-10-17
• Study Completion: 2008-03
• Status Verified: 2012-01
• Last Update Submitted: 2012-01-25
• Last Update Posted: 2012-01-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2001

Inclusion Criteria

• Patients with erosive esophagitis (endoscopical findings according to the Los Angeles Classification; grade A-D) currently not treated with a proton pump inhibitor, for whom the general practitioner (GP) has decided to initiate or change the treatment for GERD

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To gather epidemiological data in a population of GERD patients	After collection of all questionnaires

Secondary Outcome Measures

Name	Time	Method
To evaluate the added value of a new patient questionnaire (GERD Impact Scale) as a useful tool for the initial and long-term management of GERD patients: determination of the appropriate treatment and evaluation of the response to treatment.	After collection of all questionnaires

Trial Locations

Locations (1)

Research Site; 🇧🇪 Zichem, Belgium